Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia

Rituximab-combined therapeutic regimens have been recommended for treatment of Waldenström's Macroglobulinemia (WM). We report one WM patient who developed interstitial pneumonitis after rituximab therapy.

Detalles Bibliográficos
Autores principales: Bai, Xueyan, Cui, Qu, Liu, Yuanbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352371/
https://www.ncbi.nlm.nih.gov/pubmed/25798285
http://dx.doi.org/10.1002/ccr3.152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352371/
https://www.ncbi.nlm.nih.gov/pubmed/25798285
http://dx.doi.org/10.1002/ccr3.152

Ejemplares similares